The Pharmacy of the World: A 2026 Overview of India’s Pharmaceutical Sector
22 Mar 2026
Department of Pharmaceuticals DoPs
Showing 1-10 of 10 articles
Opinion
The Next Frontier for India’s Defence Against Antimicrobial Resistance Is Governance, Not Just New Drugs
Sudha Chandrashekar, Health Systems Transformation Platform (HSTP); Shambhavi Nimisha Prasad, Kempegowda Institute of Medical Sciences (KIMS); Ramesh Masthi N R, Kempegowda Institute of Medical Sciences (KIMS) ...
13 Mar 2026
Strengthening Self-Reliance in Active Pharmaceutical Ingredients
10 Mar 2026
8th Jan Aushadhi Diwas – Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
07 Mar 2026
Opinion
When Breakthrough Cancer Care Meets India’s Policy Reality
Arpita Mukherjee, Independent immunologist and Biochemist
25 Feb 2026
India’s MedTech Startups Urged to Go Global: Leveraging FTAs, Innovation Support and Global Market Access
13 Feb 2026
Rajya Sabha Q&A: India’s Dependence on Imported APIs
03 Feb 2026
Union Budget 2026-27: A Vision for Biopharmaceutical Sovereignty
01 Feb 2026
Clean Governance Push: SCDPM 4.0 Under Department of Pharmaceuticals Leads Record-Management & Scrap Disposal Reforms
15 Sept 2025
Opinion
India’s Medtech Weak Spot Could Undermine Its Healthcare Leap
Shailender Kumar Hooda, Institute for Studies in Industrial Development (ISID)
26 Aug 2025
Rethinking Public Policy Through Insight | Inquiry | Impact
Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs
An independent platform that connects research and public policy through clear, evidence-based communication, guided by an apolitical, non-partisan ethos.